4900-38-3 Usage
Uses
Used in Pharmaceutical Applications:
[(2-Oxo-1,2-dihydroquinolin-4-yl)methyl](acetylamino)malonic acid diethyl ester is used as a pharmaceutical compound for its potential role in the development of new drugs. The complex structure of the molecule may allow it to interact with various biological targets, making it a candidate for therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, [(2-Oxo-1,2-dihydroquinolin-4-yl)methyl](acetylamino)malonic acid diethyl ester is used as a synthetic building block for creating more complex molecules. Its unique functional groups can be utilized in various chemical reactions to form a wide range of organic compounds.
Used in Chemical and Biological Research:
As a research tool, [(2-Oxo-1,2-dihydroquinolin-4-yl)methyl](acetylamino)malonic acid diethyl ester is used in chemical and biological studies to investigate its interactions with different biomolecules and to understand its potential applications in various scientific disciplines.
Used in Application Industry:
[(2-Oxo-1,2-dihydroquinolin-4-yl)methyl](acetylamino)malonic acid diethyl ester is used as [application type] for [application reason]. (Note: The specific application type and reason would depend on the industry and the particular use case within that industry.)
Check Digit Verification of cas no
The CAS Registry Mumber 4900-38-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,0 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4900-38:
(6*4)+(5*9)+(4*0)+(3*0)+(2*3)+(1*8)=83
83 % 10 = 3
So 4900-38-3 is a valid CAS Registry Number.
4900-38-3Relevant academic research and scientific papers
Carbostyril derivatives
-
, (2008/06/13)
Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.